Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.86 HKD | 0.00% | +7.51% | -48.62% |
May. 01 | Jacobio Pharma Announces Its KRAS G12C Inhibitor Reached the Primary Endpoint | CI |
Apr. 25 | Jacobio Pharmaceuticals Plans Auditor Change | MT |
Evolution of the average Target Price on Jacobio Pharmaceuticals Group Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 1167 Stock
- Consensus Jacobio Pharmaceuticals Group Co., Ltd.